2 NDCS FOR OREXIN INHIBITORS. AWARDED FOR A BASE YEAR OF 5/28/2023 TO 5/27/2024 AND 4 ONE-YEAR OPTION PERIODS.

Statistical observations derived from public procurement data. Patterns identified do not constitute findings, accusations, or allegations of wrongdoing. All analysis is based on publicly available records and requires independent verification before any action is taken. This is not legal advice. Terms of Service